Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1963 1
1964 1
1965 1
1966 1
1969 2
1970 4
1971 2
1972 3
1973 5
1974 4
1975 11
1976 10
1977 17
1978 9
1979 19
1980 12
1981 24
1982 16
1983 30
1984 33
1985 34
1986 33
1987 35
1988 54
1989 70
1990 97
1991 62
1992 85
1993 71
1994 82
1995 79
1996 78
1997 77
1998 70
1999 77
2000 86
2001 96
2002 113
2003 115
2004 138
2005 129
2006 122
2007 162
2008 125
2009 136
2010 146
2011 144
2012 155
2013 177
2014 151
2015 169
2016 171
2017 166
2018 184
2019 171
2020 176
2021 159
2022 184
2023 155
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

4,465 results

Results by year

Filters applied: . Clear all
Page 1
Malignant hyperthermia: a review.
Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Rosenberg H, et al. Orphanet J Rare Dis. 2015 Aug 4;10:93. doi: 10.1186/s13023-015-0310-1. Orphanet J Rare Dis. 2015. PMID: 26238698 Free PMC article. Review.
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane, isoflurane and the depolarizing muscle relaxant succinylcholine, and rare …
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent vol …
Malignant Hyperthermia.
Kaur H, Katyal N, Yelam A, Kumar K, Srivastava H, Govindarajan R. Kaur H, et al. Mo Med. 2019 Mar-Apr;116(2):154-159. Mo Med. 2019. PMID: 31040503 Free PMC article. Review.
Malignant Hyperthermia (MH) is a life-threatening pharmacogenetic disorder which results from exposure to volatile anesthetic agents and depolarizing muscle relaxants. It manifests as a hypermetabolic response resulting in tachycardia, tachypnea, hyperthermia, hyper …
Malignant Hyperthermia (MH) is a life-threatening pharmacogenetic disorder which results from exposure to volatile anesthetic agents …
Pathophysiology and Treatment of Malignant Hyperthermia.
Gregory H, Weant KA. Gregory H, et al. Adv Emerg Nurs J. 2021 Apr-Jun 01;43(2):102-110. doi: 10.1097/TME.0000000000000344. Adv Emerg Nurs J. 2021. PMID: 33915557 Review.
Malignant hyperthermia (MH) is caused by a genetic disorder of the skeletal muscle that induces a hypermetabolic response when patients are exposed to a triggering agent such as volatile inhaled anesthetics or depolarizing neuromuscular blockers. Symptoms of MH include inc …
Malignant hyperthermia (MH) is caused by a genetic disorder of the skeletal muscle that induces a hypermetabolic response when patien …
Current concepts. The malignant hyperthermia syndrome.
Nelson TE, Flewellen EH. Nelson TE, et al. N Engl J Med. 1983 Aug 18;309(7):416-8. doi: 10.1056/NEJM198308183090706. N Engl J Med. 1983. PMID: 6348539 Review. No abstract available.
Fever--an update.
Becker JH, Wu SC. Becker JH, et al. J Am Podiatr Med Assoc. 2010 Jul-Aug;100(4):281-90. doi: 10.7547/1000281. J Am Podiatr Med Assoc. 2010. PMID: 20660880 Review.
2020 International Consensus on First Aid Science With Treatment Recommendations.
Singletary EM, Zideman DA, Bendall JC, Berry DC, Borra V, Carlson JN, Cassan P, Chang WT, Charlton NP, Djärv T, Douma MJ, Epstein JL, Hood NA, Markenson DS, Meyran D, Orkin AM, Sakamoto T, Swain JM, Woodin JA; First Aid Science Collaborators. Singletary EM, et al. Circulation. 2020 Oct 20;142(16_suppl_1):S284-S334. doi: 10.1161/CIR.0000000000000897. Epub 2020 Oct 21. Circulation. 2020. PMID: 33084394 Free article. Review.
This summary addresses the topics of first aid methods of glucose administration for hypoglycemia; techniques for cooling of exertional hyperthermia and heatstroke; recognition of acute stroke; the use of supplementary oxygen in acute stroke; early or first aid use of aspi …
This summary addresses the topics of first aid methods of glucose administration for hypoglycemia; techniques for cooling of exertional h
First aid cooling techniques for heat stroke and exertional hyperthermia: A systematic review and meta-analysis.
Douma MJ, Aves T, Allan KS, Bendall JC, Berry DC, Chang WT, Epstein J, Hood N, Singletary EM, Zideman D, Lin S; First Aid Task Force of the International Liaison Committee on Resuscitation. Douma MJ, et al. Resuscitation. 2020 Mar 1;148:173-190. doi: 10.1016/j.resuscitation.2020.01.007. Epub 2020 Jan 22. Resuscitation. 2020. PMID: 31981710 Review.
BACKGROUND: Heat stroke is an emergent condition characterized by hyperthermia (>40 C/>104 F) and nervous system dysregulation. There are two primary etiologies: exertional which occurs during physical activity and non-exertional which occurs during extreme heat even …
BACKGROUND: Heat stroke is an emergent condition characterized by hyperthermia (>40 C/>104 F) and nervous system dysregulation. …
Mutations in RYR1 in malignant hyperthermia and central core disease.
Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Robinson R, et al. Hum Mutat. 2006 Oct;27(10):977-89. doi: 10.1002/humu.20356. Hum Mutat. 2006. PMID: 16917943 Review.
Mutations in the gene have been found in association with several diseases: the pharmacogenetic disorder, malignant hyperthermia (MH); and three congenital myopathies, including central core disease (CCD), multiminicore disease (MmD), and in an isolated case of a congenita …
Mutations in the gene have been found in association with several diseases: the pharmacogenetic disorder, malignant hyperthermia (MH) …
Malignant hyperthermia.
Hopkins PM, Gupta PK, Bilmen JG. Hopkins PM, et al. Handb Clin Neurol. 2018;157:645-661. doi: 10.1016/B978-0-444-64074-1.00038-0. Handb Clin Neurol. 2018. PMID: 30459030 Review.
Malignant hyperthermia (MH) is a form of heat illness caused by increased heat generation exceeding the body's capacity for heat loss. ...
Malignant hyperthermia (MH) is a form of heat illness caused by increased heat generation exceeding the body's capacity for heat loss …
4,465 results